Product
DZ-002
1 clinical trial
2 indications
Indication
Solid TumorIndication
lymphomaClinical trial
A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or LymphomaStatus: Recruiting, Estimated PCD: 2025-01-01